Company news

Moleculin Biotech, Inc. news in 2019

Moleculin Biotech, Inc.'s news releases, calls and decks from 2019, newest first.

View company

Moleculin Announces Additional Positive Interim Results from Phase 1/2 Clinical Studies of Annamycin in Acute Myeloid Leukemia

December 3, 2019

Moleculin Announces Positive Trial Data with 100% Safe Delivery of p-STAT3 Inhibitor and Efficacy in Majority of Patients

November 18, 2019

Moleculin Announces Beginning of Preclinical Development of New Approach to Pancreatic Cancer

November 12, 2019

Moleculin Announces FDA Approval of IND for its STAT3 Inhibitor in Emory University Clinical Trial

November 11, 2019

Moleculin Announces New Data Confirms Anti-tumor Efficacy of Annamycin in Both Human and Murine AML Models

October 28, 2019

Moleculin Increases Annamycin Production Due to Positive Clinical Trial Activity and Expanded Potential Indications

October 21, 2019

Moleculin Announces its Sponsored Research at MD Anderson Cancer Center Has Resulted in the Filing of Patent Protection for New Discovery

September 15, 2019

Moleculin Biotech, Inc. Reports Financial Results for the Second Quarter Ended June 30, 2019

August 15, 2019

Moleculin Announces Completion of Lymphoma Trial Enrollment

August 12, 2019

Moleculin Announces Breakthrough Discovery: WP1066 Potentially Capable of Immune Reprogramming in Glioblastoma Animal Models

August 5, 2019

Moleculin Announces Annamycin in Acute Myeloid Leukemia in Poland Advances to 3rd Cohort

July 17, 2019

Moleculin Files for New Patents for Annamycin After Receiving FDA Approval of Fast Track Designation

July 9, 2019

Moleculin Biotech, Inc. Reports Financial Results for the First Quarter Ended March 31, 2019

May 13, 2019

Moleculin Announces Conference Call to Discuss Significant Discovery For Lung Cancer and FDA Activity on Wednesday, April 24, 2019

April 21, 2019

Moleculin Receives FDA Approval of Fast Track Designation for Annamycin

April 17, 2019

Moleculin Announces Significant Discovery in Lung Cancer Models

April 16, 2019

Moleculin Announces Agreement with Emory University to Conduct Pediatric Brain Tumor Trial

April 10, 2019

Moleculin Announces Successful Expansion of its Leukemia Drug Program

April 8, 2019

Moleculin Announces Preclinical Pancreatic Cancer Data Presented at American Association for Cancer Research Annual Meeting

April 2, 2019

Decks in 2019